Zhu L - Search Results

1

Self-catalyzed nitric oxide nanocomplexes induce ferroptosis for cancer immunotherapy.

Zhu L, Leng D, Guo Z, Zhao Y, Leung KT, Dai Y, Li J, Zhao Q. Zhu L, et al. J Control Release. 2025 Jan 10;377:524-539. doi: 10.1016/j.jconrel.2024.11.048. Epub 2024 Nov 28. J Control Release. 2025. PMID: 39580079

2

Synergistic combination of targeted nano-nuclear-reactors and anti-PD-L1 nanobodies evokes persistent T cell immune activation for cancer immunotherapy.

Zhu L, Li J, Guo Z, Kwok HF, Zhao Q. Zhu L, et al. J Nanobiotechnology. 2022 Dec 10;20(1):521. doi: 10.1186/s12951-022-01736-8. J Nanobiotechnology. 2022. PMID: 36496381 Free PMC article.

3

A biomimetic cuproptosis amplifier for targeted NIR-II fluorescence/photoacoustic imaging-guided synergistic NIR-II photothermal immunotherapy.

Dai Y, Zhu L, Li X, Zhang F, Chen K, Jiao G, Liu Y, Yang Z, Guo Z, Zhang B, Shen Q, Zhao Q. Dai Y, et al. Among authors: zhu l. Biomaterials. 2024 Mar;305:122455. doi: 10.1016/j.biomaterials.2023.122455. Epub 2023 Dec 27. Biomaterials. 2024. PMID: 38160626

4

Metal-Coordinated NIR-II Nanoadjuvants with Nanobody Conjugation for Potentiating Immunotherapy by Tumor Metabolism Reprogramming.

Dai Y, Guo Z, Leng D, Jiao G, Chen K, Fu M, Liu Y, Shen Q, Wang Q, Zhu L, Zhao Q. Dai Y, et al. Among authors: zhu l. Adv Sci (Weinh). 2024 Sep;11(34):e2404886. doi: 10.1002/advs.202404886. Epub 2024 Jul 7. Adv Sci (Weinh). 2024. PMID: 38973161 Free PMC article.

5

Tumor Microenvironment-Modulated Nanozymes for NIR-II-Triggered Hyperthermia-Enhanced Photo-Nanocatalytic Therapy via Disrupting ROS Homeostasis.

Zhu L, Dai Y, Gao L, Zhao Q. Zhu L, et al. Int J Nanomedicine. 2021 Jul 5;16:4559-4577. doi: 10.2147/IJN.S309062. eCollection 2021. Int J Nanomedicine. 2021. PMID: 34267513 Free PMC article.

6

Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy.

Dai Y, Li X, Xue Y, Chen K, Jiao G, Zhu L, Li M, Fan Q, Dai Y, Zhao Q, Shen Q. Dai Y, et al. Among authors: zhu l. Acta Biomater. 2023 Aug;166:496-511. doi: 10.1016/j.actbio.2023.05.032. Epub 2023 May 23. Acta Biomater. 2023. PMID: 37230439

7

Nanoenabled intracellular zinc bursting for efficacious reversal of gefitinib resistance in lung cancer.

Li J, Assaraf YG, Zuo W, Lin Z, Leong KW, Zhao Q, Zhu L, Kwok HF. Li J, et al. Among authors: zhu l. Int J Biol Sci. 2024 May 19;20(8):3028-3045. doi: 10.7150/ijbs.95929. eCollection 2024. Int J Biol Sci. 2024. PMID: 38904022 Free PMC article.

8

Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment.

Li J, Zhu L, Kwok HF. Li J, et al. Among authors: zhu l. Drug Resist Updat. 2023 Jan;66:100904. doi: 10.1016/j.drup.2022.100904. Epub 2022 Nov 28. Drug Resist Updat. 2023. PMID: 36462375 Review.

9

NIR II-Excited and pH-Responsive Ultrasmall Nanoplatform for Deep Optical Tissue and Drug Delivery Penetration and Effective Cancer Chemophototherapy.

Zhu L, Gao D, Xie L, Dai Y, Zhao Q. Zhu L, et al. Mol Pharm. 2020 Oct 5;17(10):3720-3729. doi: 10.1021/acs.molpharmaceut.0c00404. Epub 2020 Sep 3. Mol Pharm. 2020. PMID: 32633977

10

Remodeling of Tumor Microenvironment by Tumor-Targeting Nanozymes Enhances Immune Activation of CAR T Cells for Combination Therapy.

Zhu L, Liu J, Zhou G, Liu TM, Dai Y, Nie G, Zhao Q. Zhu L, et al. Small. 2021 Oct;17(43):e2102624. doi: 10.1002/smll.202102624. Epub 2021 Aug 10. Small. 2021. PMID: 34378338

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,767 results

Search Page

Filters